[at noodls] – PRESS RELEASE Genzyme’s Multiple Sclerosis Franchise Featured at AAN – Multiple Presentations Highlight Continuing Progress of AUBAGIO and LEMTRADA Programs – Paris, France – March 13, 2013 – Sanofi (EURONEXT: … moreView todays social media effects on SNYView the latest stocks trending across Twitter. Click to view dashboardSee who Sanofi is hiring next, click here to view […]
[at noodls] – PRESS RELEASE Paris, France – March 5, 2013 – At its meeting held on March 5, 2013, the Board of Directors of Sanofi decided to propose the appointment of a new independent Director, Mrs. Fabienne Lecorvaisier, … moreView todays social media effects on SNYView the latest stocks trending across Twitter. Click to view dashboardSee who Sanofi is […]
[at noodls] – PRESS RELEASE , an IL-4R alpha Antibody, in Atopic Dermatitis – Phase 1b Data Presented at Late Breaking Session of 71st Annual Meeting of the American Academy of Dermatology – Paris, France and Tarrytown, … moreView todays social media effects on SNYView the latest stocks trending across Twitter. Click to view dashboardSee who Sanofi is hiring next, […]
[at noodls] – PRESS RELEASE European Medicines Agency Recommends Approval of Hexyon/Hexacima 6-in-1 Pediatric Vaccine – Hexyon/Hexacima will be the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine in Europe … moreView todays social media effects on SNYView the latest stocks trending across Twitter. Click to view dashboardSee who Sanofi is hiring next, click here to view […]
[at noodls] – PRESS RELEASE Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA Paris, France – February 19, 2013 – Sanofi (EURONEXT : SAN and NYSE : SNY) announced today that the U.S. Food and Drug … moreView todays social media effects on SNYView the latest stocks trending across Twitter. Click to view dashboardSee who Sanofi is […]
